Research & Innovations

Explore groundbreaking studies in medicinal chemistry, drug design methodologies, and therapeutic discovery

Research Articles

Beyond Blood Sugar: Could a Common Diabetes Drug Be a Kidney's Best Shield?

Exploring the potential of Empagliflozin, an SGLT2 inhibitor, in preventing Acute Kidney Injury (AKI) based on the landmark EMPA-KIDNEY trial results.

Elijah Foster
Oct 14, 2025

Popular Articles